Recombinant Anti-Anthrax Lethal Toxin Antibody (Fc glycosylation) (CAT#: Gly-132LC)
This product is a human monoclonal antibody with glycosylation site in Fc region. The glycosylated antibody maintain the effector function. AVP-22G12 specficfically binds to anthrax lethal toxin and can be potentially used in the treatment of anthrax.
Specific Inquiry
Glyco-engineering
- Glycosylation site
- Fc region
- Glycosylation Type
- N-glycosylation
- Activity
- Maintain the effector functions
Specifications
- Target
- Anthrax Lethal Toxin
- Host Species
- Human
- Type
- Human antibody
- Clone
- AVP-22G12
- Applications
- ELISA
Target
- Alternative Names
- Anthrax Lethal Toxin
- Related Disease
- Anthrax
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Anthrax Lethal Toxin"
Fc Glycosylation
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-133LC | Recombinant Anti-Anthrax Lethal Toxin Antibody (Fc glycosylation) | ELISA | Human antibody |
Deglycosylated Antibody (Non-glycosylated IgGs)
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-172LC | Recombinant Anti-Human Anthrax Lethal Toxin Antibody (Non-glycosylated) | ELISA | Human antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for Gly-132LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.